Concepedia

Shilin Xue

SX

Statistics

Publications

4

Citations

117

H-Index

4

Active since

2022

Affiliations

Sun Yat-sen University Cancer Center(Current)

Sun Yat-sen University

Peking University

Shilin Xue is an author at Sun Yat-sen University Cancer Center specializing in pharmacology, non-small cell lung cancer therapy, and immunotherapy.

ORCID

Publications per year

2022–2024

4

Publications

4

First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors

Yuanyuan Zhao, Yuxiang Ma, Aimin Zang et al. · Journal of Hematology & Oncology · 2023 · 50 citations · Full text

, , +17

Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis

Ankang Peng, Shun-Zhi Liu, Lu Fang et al. · European Journal of Pharmacology · 2022 · 30 citations

, , +7

QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study

Yan Huang, Yunpeng Yang, Yuanyuan Zhao et al. · Signal Transduction and Targeted Therapy · 2024 · 20 citations · Full text

, , +17

The association between air pollution, meteorological factors, and daily outpatient visits for urticaria in Shijiazhuang, Hebei Province, China: a time series analysis

Lijuan Liu, Shilin Xue, Lina Yan et al. · Environmental Science and Pollution Research · 2022 · 17 citations

, , +17

1–4 of 4